Form D · Pharmaceuticals
Osteal Therapeutics, Inc.
Dallas, TX · CIK 0001735936
Offering snapshot reported Nov 5, 2025 · SEC filing
- Reported sold
- $15.6M Offering amount: $26.7M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 17, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 5, 2025 | Initial | $15,602,151 | No comparison | 10 | SEC filing |
| Jun 6, 2024 | Initial | $49,999,926 | No comparison | 16 | SEC filing |
| Sep 12, 2023 | Initial | $22,285,675 | No comparison | 19 | SEC filing |
| Dec 30, 2021 | Initial | $30,248,730 | No comparison | 59 | SEC filing |
| Jan 12, 2021 | Amendment | $2,000,000 | $535,000vs Nov 23, 2020 | 25 | SEC filing |
| Nov 23, 2020 | Initial | $1,465,000 | No comparison | 17 | SEC filing |
| Apr 6, 2018 | Initial | $7,412,261 | No comparison | 45 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-563186
Source: Form D, filed Nov 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Cash | Director |
| Judson Cooper | Director |
| Brian De Beaubien | Director, Executive |
| Douglas Kohrs | Director |
| Noam Krantz | Director |
| Rushu Luo | Director |
| Biren Mehta | Director |
| Erik Oros | Director |
| Jude Paganelli | Director, Executive |
| Sonal Patel | Director |
| Renee Ryan | Director |
| Martin Sands | Director |
| David Thompson | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4835 Lyndon B. Johnson Fwy Ste 635
Dallas, TX, 75244
Phone: (469) 809-2630
Dallas, TX, 75244
Phone: (469) 809-2630